Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Cergutuzumab amunaleukin
Trade Name
Synonyms RO6895882|RG7813|CEA TCB|RG-7813
Drug Descriptions

Cergutuzumab amunaleukin (RG7813) is a bispecific antibody that binds carcinoembyronic antigen (CEA) and CD3, potentially resulting in enhanced T-cell response to CEA-expresssing tumor cells (European Journal of Cancer, Volume 51, Supplement 1, March 2015, Page S13, PMID: 28405498).

DrugClasses CD3 Antibody 93
CAS Registry Number 1509916-03-3
NCIT ID C141459

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cergutuzumab amunaleukin Cergutuzumab amunaleukin 0 2


Additional content available in CKB BOOST